By: IPP Bureau
Last updated : October 27, 2021 9:14 am
The Board of Directors of Sanofi India Limited, at its meeting held on October 26th 2021 have approved the unaudited Standalone financial results of the company for the period ended September 30, 2021
For the quarter ended September 30, 2021 (Q3 CY2021), the company's total income was Rs 769.2 crore, against Rs 701.5 crore in the corresponding quarter of the previous year (YoY) and Rs 806.2 crore in the previous quarter (QoQ).
For the quarter ended September 30, 2021 (Q3 CY2021), the company's net profit was Rs 529.8 crore, against Rs 132.9 crore in the corresponding quarter of the previous year (YoY) and Rs 178.3 crore in the previous quarter (QoQ).
For the 9 months ended September 30, 2021 (9 Months Ended CY 2021), the company's total income was Rs 2326.8 crore, against Rs 2255.2 crore in the previous year (YoY) (9 Months Ended CY 2020).
The net profit was at Rs 854 crore for the 9 months ended September 30, 2021 (9 Months Ended CY 2021), compared to ₹354.6 crore in the previous year (YoY) (9 Months Ended CY 2020).